The 2024 international workshop on Alport syndrome

14-16 March, 2024
Nicosia, Cyprus

ENYO Pharma is sponsoring and will attend The 2024 International Workshop on Alport syndrome organized by the Alport Syndrome Alliance, an international patient-driven collaboration.

ENYO Pharma will meet Alport syndrome patients and their families to present its starting Phase 2 “ALPESTRIA-1” clinical study with Vonafexor in Alport syndrome patients.

https://www.alportsyndromealliance.org/